Syneos Health Acquires Illingworth Research Group, a Leading Provider of Clinical Research Home Health Services
A pioneer in the clinical trial home health space,
The acquisition adds new scale and capabilities to Syneos Health’s decentralized clinical trial solutions. Syneos Health’s Decentralized Solutions strategy seeks to bring flexibility to each customers’ study, fueled by data, people, process and technology.
“The patient-focused solutions provided by
“Joining Syneos Health offers significant opportunities to utilize our in-home clinical research expertise at greater scale, with the goal of enabling more patients to participate in trials,” said
Illingworth Research Group™, a
Except for historical information, all of the statements, expectations, and assumptions contained in this press release are forward-looking statements as that term is defined in the Private Securities Litigation Reform Act of 1995, including the benefits of our acquisition of
Senior Vice President, Investor Relations
+1 919 745 2745
+1 202 210 5992
Syneos Health, Inc.